lungs

Managing COPD patients

By healthcare professionals for healthcare professionals

From diagnosis to review, explore expert led content to help you give COPD patients the right treatment.

Confirming a COPD Diagnosis in a Hybrid Clinical Setting

Presented by: Frances Barrett BSc (Hons), RGN, Respiratory and First Aid Trainer

Summary:

Frances explores the importance of collating essential history, reflecting on previous objective examinations and completing key subjective assessments to elicit treatable traits and biomarkers in order support your patients COPD symptoms now and in the future.

Got more learning to do?

Sign up for a GSKpro account to get access to videos including:

  • How to conduct a medicines optimisation search for COPD patients utilising ‘EMIS’
  • How to conduct a medicines optimisation search for COPD patients utilising ‘System One’
  • How to conduct a medicines optimisation search for COPD patients utilising ‘Vision’
  • Optimising prescribing for Chronic Obstructive Pulmonary Disease (COPD) patients
  • Reviewing the exacerbating COPD patient
  • Reviewing the breathless COPD patient
  • Confirming a COPD Diagnosis in a Hybrid Clinical Setting

Log in or register below.

Trademarks are the property of their respective owners. ANORO Ellipta (umeclidinium/vilanterol) and TRELEGY Ellipta (fluticasone furoate/umeclidinium/vilanterol) Prescribing Information is available here. Anoro Ellipta and Trelegy Ellipta were developed in collaboration with INNOVIVA

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441.

May 2022 | PM-GB-RS-WCNT-220002 (V1.0)